Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer

Por Ferris, R. L., Geiger, J. L., Trivedi, S., Schmitt, N. C., Heron, D. E., Johnson, J. T., Kim, S., Duvvuri, U., Clump, D. A., Bauman, J. E., Ohr, J. P., Gooding, W. E., Argiris, A.
Publicado no Ann Oncol (2016)

IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer

Por Stabile, L.P., Egloff, A.M., Gibson, M.K., Gooding, W.E., Ohr, J., Zhou, P., Rothenberger, N.J., Wang, L., Geiger, J.L., Flaherty, J.T., Grandis, J.R., Bauman, J.E.
Publicado no Oral Oncol (2017)